Quest Diagnostics Inc

DGX

183.460USD

+3.350+1.86%

Close 09/05, 16:00（ET）Quotes delayed by 15 min

Score

Industry at a Glance

Industry Ranking

57 / 280

Overall Ranking

157 / 4732

Industry

Healthcare Services & Equipment

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 20 analysts

Buy

Current Rating

187.646

Target Price

+4.53%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The Company also focuses on artificial intelligence (AI) and digital pathology solutions for biopharmaceutical companies and pathology laboratories. It has implemented AI, digital and automation technologies across several laboratory and business functions.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 38.22%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 38.22%.

Fairly Valued

The company’s latest is 21.21, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 107.55M shares, decreasing 2.90% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 14.18M shares of this stock.

The company's current financial score is 7.39, which is higher than the Healthcare Services & Equipment industry's average of 7.15. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 2.65B, representing a year-over-year increase of 12.09%, while its net profit experienced a year-over-year increase of 13.47%.

Score

Industry at a Glance

Previous score

7.39

Change

0



Financials

6.42

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.54

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.54

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.36

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

8.11

Key Metrics

Free cash flow

No Data

The company’s current valuation score is 1.80, which is lower than the Healthcare Services & Equipment industry's average of 2.15. Its current P/E ratio is 21.17, which is 2.57% below the recent high of 21.72 and 3.14% above the recent low of 20.51.

Score

Industry at a Glance

Previous score

1.80

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 57/280

No Data

The company’s current earnings forecast score is 7.60, which is lower than the Healthcare Services & Equipment industry's average of 7.66. The average price target for Quest Diagnostics Inc is 190.00, with a high of 200.00 and a low of 158.69.

Score

Industry at a Glance

Previous score

7.40

Change

0

Support & Resistance

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The company’s current price momentum score is 9.08, which is higher than the Healthcare Services & Equipment industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 188.00 and the support level at 169.14, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.19

Change

-0.01

Support & Resistance

No Data

Institutional Confidence

Currency: USD Updated：2025-09-04

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Services & Equipment industry's average of 7.19. The latest institutional shareholding proportion is 96.17%, representing a quarter-over-quarter decrease of 1.06%. The largest institutional shareholder is The Vanguard, holding a total of 14.18M shares, representing 12.68% of shares outstanding, with 1.21% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

13.89M

-0.17%

T. Rowe Price Associates, Inc.

Star Investors

5.82M

+9.21%

BlackRock Institutional Trust Company, N.A.

6.37M

-0.10%

State Street Global Advisors (US)

5.18M

-0.85%

JP Morgan Asset Management

3.31M

+56.51%

Boston Partners

2.30M

+280.33%

Geode Capital Management, L.L.C.

2.77M

+3.13%

Victory Capital Management Inc.

3.13M

-6.74%

Dimensional Fund Advisors, L.P.

1.91M

-6.31%

Wells Fargo Advisors

1.75M

+25.14%



1

2



The company's beta value is 0.54. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Quest Diagnostics Inc

DGX

6.71 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Insulet Corp

PODD

7.90 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Merit Medical Systems Inc

MMSI

7.80 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Tenet Healthcare Corp

THC

7.66 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Brightspring Health Services Inc

BTSG

7.66 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

7.62 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.